Welcome to the CME Portal!

https://dmgaz.zoom.us/j/96336555388?pwd=S3pMcmg2ZkFQN0xrSkpwVktBT1VHdz09

Meeting ID: 963 3655 5388
Passcode: 762046

Contact Megan Jehlicka to claim CME credit for this session:

Office: 602.344.5418 | Cell: 775.846.5924; Email: megan_jehlicka@dmgaz.org

Pediatric Grand Rounds Presenting live from Cohen Conference Center Dr. Who, Me? Professional Identity Formation in Physicians At the end of this presentation, participants should be able to: Explain the theoretical basis behind professional identity formation. Recognize the challenges physicians-in-training face in developing a professional persona. Identify steps medical educators can take to support professionalization in trainees. Zoom details below:

https://dmgaz.zoom.us/j/96336555388?pwd=S3pMcmg2ZkFQN0xrSkpwVktBT1VHdz09

Meeting ID: 963 3655 5388
Passcode: 762046

Contact Megan Jehlicka to claim CME credit for this session:

Office: 602.344.5418 | Cell: 775.846.5924; Email: megan_jehlicka@dmgaz.org

Children’s Neuroscience Grand Rounds

Early circuit-directed rehabilitation mitigates late-onset sensory hypersensitivity after traumatic brain injury

Presented by: Gokul Krishna, PhD

Learning Objectives:

1. Recognize the contribution of maladaptive circuit reorganization as a pathophysiological process underlying late-onset neurological deficits after concussive brain injury.
2. Evaluate the efficacy of early rehabilitation for lessoning deficit severity and improving circuit function in a well-established model of diffuse axonal injury.

Early pharmacological intervention with gabapentin inhibits traumatic brain injury-mediated synaptogenesis in rats

Student Presenter: Caitlin Hair, PhD 

Learning Objectives:

1. Describe traumatic brain injury-induced upregulation of thrombospondins implicated in increased-synaptogenesis as a pivotal process in maladaptive circuit reorganization. 
2. Evaluate the efficacy of early gabapentin treatment to inhibit maladaptive synaptogenesis and improve long-term outcomes.
3. Discuss clinical possibilities of prophylactic use of gabapentin after in TBI patients.

Neuropathology and vulnerability to traumatic brain injury in a mouse model of connective tissue disorders

Presented by: Tala Curry, PhD (Candidate)

Learning Objectives:

1. Identify that connective tissue disorder (CTD) patient populations may be at risk for elevated severity of symptoms after traumatic brain injury.
2. Recognize Marfan Syndrome (CTD) and associated downstream signaling can contribute to neuropathology.

Meet the presenter:

Nicole Green, M.D. was born in London, United Kingdom. She moved to the United States of America for college where she received a BA degree from Amherst College and an MD from Columbia University-College of Physicians and Surgeons. Dr. Green completed Pediatric residency at New York Presbyterian Hospital-Weill Cornell before moving to Seattle for Pediatric GI fellowship at the University of Washington. Dr. Green is currently an Assistant Professor of Pediatrics at the University of Washington School of Medicine and an attending physician in the Division of Gastroenterology and Hepatology at Seattle Children’s Hospital. Dr. Green’s academic mission is to improve the gastrointestinal (GI) outcomes of patients with cystic fibrosis (CF). She received a DIGEST Award from the Cystic Fibrosis Foundation, a 3-year grant designed to build clinical expertise in the GI care of cystic fibrosis patients. She has established a research and clinical focus in CF-associated GI and liver disease. During GI fellowship she designed a prospective pilot study assessing the feasibility of a dietary intervention (exclusion of processed foods) to influence GI symptoms, intestinal inflammation and stool microbiome in pediatric patients with cystic fibrosis. She is a site P.I. for PUSH, a NIDDK-sponsored multi-institutional study aimed at determining the utility of abdominal ultrasound, as well as other imaging modalities and biomarkers, to predict the development of advanced liver disease in pediatric patients with cystic fibrosis. She was recently awarded her institution’s clinician research scholars award to support further research in CF-liver disease and the interaction with the GI microbiome. Dr. Green enjoys multi-institutional projects and is collaborating on CF-related projects both at a national and international level with the goal of continuing to lead advancements in the field of CF GI and liver disease. In her free time, Dr Green enjoys running and races at the elite level in marathons in the US and UK.

Guest Presenter: Thomas Keens, MD, Director, Cystic Fibrosis Center, Attending Physician, Professor of Pediatrics, Physiology and Biophysics, Keck School of Medicine of USC, Children's Hospital Los Angeles

Clinical Interests

Cystic fibrosis, Sudden infant death syndrome, Congenital central hypoventilation syndrome (CCHS), Chronic respiratory failure and home mechanical ventilation, Pediatric respiratory physiology

At the end of this presentation, participants should be able to:

1. Define sudden infant death syndrome (SIDS) and known basic demographics
2. Review current research on possible causes of SIDS
3. Know SIDS risk reduction actions which reduce the chance of a baby dying from SIDS

Details will be provided at a later date.

Recorded session is for internal use only. Please email apeoples@phoenixchildrens.com to receive access information. 

Presentation details will be provided at a later date.

The Critical Role of Quality Improvement in Improved Clinical Outcomes: Two Real-life Examples at Phoenix Children’s Making a Big Impact

Presenter: Dr. Shiraz Maskatia, Clinical Professor of Pediatrics at Stanford

Innovation in Pediatric Cardiac Imaging

At the end of this presentation, participants should be able to:

1. Describe the variable clinical presentation of coarctation of the aorta 
2. Compare the outcomes of various forms of hypoplastic left heart syndrome
3. Describe the risk for sudden cardiac death in children and adolescents with anomalous origin of the coronary artery

High Risk Fetal Conditions:  Cardiac Evaluation and Potential for Prenatal Therapy/Intrapartum/Postnatal Therapy  

March 26, 2024 – 7:30 AM

In Person at the Cohen Conference Center and Live Streamed

Presented by: Nicholas Behrendt, MD and Christopher Lindblade, MD 

Overall Activity Objectives:

1 Implement appropriate strategies for diagnosing pediatric conditions.

2 Evaluate and implement appropriate, current treatment options vis a vis emerging therapeutics.

3 Implement in practice developing areas of research and evidence-based recommendations within a diverse range of pediatric specialties.                                                                                                                                                             

Session Objectives:

• Discuss high risk fetal conditions (e.g. sacrococcygeal teratoma, vein of Galen malformation, placental chorioangioma, etc) and their cardiovascular implications

• Present options for prenatal monitoring and intervention for high risk fetal conditions

• Discuss the perinatal management for high risk fetal conditions and postnatal outcomes

Guest Speaker: Robert Listernick, MD

Grand Rounds "Neurofibromatosis Type 1 in Children"

At the end of this presentation, participants should be able to:

• Demonstrate proficiency in distinguishing between the various forms of neurofibromatosis syndromes in children
• Demonstrate proficiency in recognizing the early manifestations of neurofibromatosis type 1 in children

At the end of this presentation, participants should be able to:

• Associate the Indications for Imaging in Headache.
• Recognize the common Imaging Findings in Secondary Headache.
• Identify which studies are inappropriate in specific Headache situations.

Children’s Neuroscience Grand Rounds 

Recording available for internal purposes only. Please contact Christina Casanova to request access.

Demystifying Functional Neurological Disorders 

Presented by: Amy Schaefer, PsyD 

Learning Objectives:

1. Identify risk factors, presentations, outcomes, and biases associated with functional movement disorders and functional [nonepileptic] seizures
2. Discuss updated recommendations for evidence-based evaluation, diagnosis, and treatment of functional neurological disorders
3. Review current functional neurological disorder guidelines created by interdisciplinary teams at Phoenix Children's

At the end of this presentation, participants should be able to:

1. Identify the new problems facing the ability to StayCurrent in medical knowledge.

2. Implement new technology that may help solve the problem of information overload

3. Recognize the value of modifying how we tell the story of important medical information using media

Presenter: Todd Ponsky, MD, Professor of Surgery and Director of Clinical Growth and Transformation at Cincinnati Children’s Hospital

Presentation recording will be provided at a later date.

CME Credit will not be available for watching the recorded session.

Detailed presentation information will be provided at a later date.

Speaker panel:

Dr. Hoffman, Brain Tumors

Dr. Kothari, Solid Tumors

Patti Luttrell, Community Resources and Support

Objective: To increase awareness among general pediatricians about childhood cancer. 

Pediatric Grand Rounds *Via Zoom*

https://dmgaz.zoom.us/j/96336555388?pwd=S3pMcmg2ZkFQN0xrSkpwVktBT1VHdz09

Meeting ID: 963 3655 5388
Passcode: 762046

Contact Megan Jehlicka to claim CME credit for this session:

Office: 602.344.5418 | Cell: 775.846.5924; Email: megan_jehlicka@dmgaz.org

Children’s Neuroscience Grand Rounds 

Presenter: Guinnevere Baranowski, MPsy, Med 

The Impact of Interpreters on Therapeutic Alliance in Psychotherapy

Learning Objectives

1. Summarize research findings regarding the impact of interpreters on therapeutic alliance in psychotherapy.

2. Implement strategies for promoting therapeutic alliance with patients requiring interpreters.

PCH Grand Rounds - Podiatry for the General Pediatrician - Sophia Stocks, DPM

At the conclusion of this presentation, participants should be able to:

• Define dysphagia and feeding problems related to esophageal inflammation
• Describe the epidemiology and demographics of children with EoE
• Outline the pathophysiology and clinical features of eosinophilic esophagitis (EoE)
• Analyze the pathophysiology and diagnosis of reflux and gastroesophageal reflux disease (GERD) and the long-term complications of GERD; clues to an inter-relationship with EoE
• Evaluate the biological plausibility underlying the intersect between GERD and EoE
  • True-True and unrelated
  • Cause and effect; reflux first then EoE…
  • Briefly review treatment approaches and future directions

MEET THE PRESENTER

Dr. Benjamin D. Gold is a pediatric gastroenterologist in Atlanta, Georgia and is affiliated with multiple hospitals in the area, including Children's Healthcare of Atlanta and Northside Hospital Forsyth. He received his medical degree from George Washington University School of Medicine and has been in practice for more than 20 years.

Presenting live from Cohen Conference Center or via Live Stream

Presenters:

Rachel C. Lombardo, MD,

Pediatrician, Genetics and Metabolism, Phoenix Children's

Pamela Smith, MD, 

Medical Director, Metabolic Bone & Osteogenesis Imperfecta (OI) Clinic, Phoenix Children's

Maegen Wallace, MD, 

Surgical Director, Metabolic Bone and Osteogenesis Imperfecta (OI) Clinic, Phoenix Children's

At the end of this presentation, participants should be able to:

1. Describe the various subtypes of Osteogenesis Imperfecta and the associated genetic findings. 
2. Discuss what's new in the medical and surgical management of Osteogenesis Imperfecta

PCH - Duchenne Muscular Dystrophy with a History of Phoenix Children's - Dr. Saunder Bernes

Children’s Neuroscience Grand Rounds 

04-Mar-24

The Phoenix Children’s Deep Brain Stimulation Program

Michael Kruer, MD

Presenters:  Dr. Michael Nguyen & Dr. Ramin Jamshidi

At the end of this presentation, participants should be able to:

1) Outline the history of robotics in surgery

2) Describe the advantages and disadvantages of robotic surgery

3) Understand the finances of surgical robots

At the end of this presentation, participants should be able to:

• List available tests to characterize Immune status
• Describe the distinguishing features of combined immunodeficiency
• Identify potential barriers for off-label immunomodulation in pediatric rare diseases

Guest presenter: Nicolas Bamat, MD, MSCE, Division of Neonatology at Children's Hospital of Philadelphia

Learning objectives will be provided at a later date.

PCH - Heart Failure and Heart Transplant in Adult Congenital Heart Disease - Dr. Jonathan Menachem

Pediatric Grand Rounds *Via Zoom*

https://dmgaz.zoom.us/j/96336555388?pwd=S3pMcmg2ZkFQN0xrSkpwVktBT1VHdz09

Meeting ID: 963 3655 5388
Passcode: 762046

Contact Megan Jehlicka to claim CME credit for this session:

Office: 602.344.5418 | Cell: 775.846.5924; Email: megan_jehlicka@dmgaz.org

Children’s Neuroscience Grand Rounds 

Presenter: Harlori Bains, MD

Helen DeVos Children's Hospital

Laura L. Sweetman Invited Lectureship 

Neuroscience Grand Rounds

** In- Person**

Phoenix Children's Hospital, Main Campus

Ambulatory Building, 3^rd Floor Neuroscience Classroom

Pediatric Neuroimmunology - A Case Based Approach

About the presenter: Harlori K. Bains, MD, is a board-certified physician specializing in pediatric neurology. Dr. Bains earned her medical degree from Wayne State University in Detroit. She completed her pediatric neurology residency at Phoenix Children’s Hospital/Maricopa Medical Center in Arizona and her neuroimmunology fellowship at Barrow Neurological Institute in Phoenix. Her clinical interests include pediatric-onset multiple sclerosis, neuromyelitis optica, transverse myelitis, autoimmune encephalitis, acute flaccid myelitis and acute disseminated encephalomyelitis.Top of Form

Top of Form

Learning Objectives

1. Identify the clinical differences in pediatric neuroimmunological conditions. 

2. Describe the breadth of diagnostic studies and treatment options in pediatric neuroimmunological conditions.

    

Harlori K. Bains, MD, is a board-certified physician specializing in pediatric neurology. Dr. Bains earned her medical degree from Wayne State University in Detroit. She completed her pediatric neurology residency at Phoenix Children’s Hospital/Maricopa Medical Center in Arizona and her neuroimmunology fellowship at Barrow Neurological Institute in Phoenix. Her clinical interests include pediatric-onset multiple sclerosis, neuromyelitis optica, transverse myelitis, autoimmune encephalitis, acute flaccid myelitis and acute disseminated encephalomyelitis.

Cannabis Takes Page from the Tobacco Advertising Playbook: Repeating a Public Health Crisis

Detailed presentation information will be provided at a later date.

Live in Phoenix Children's Conference Center Room 102

The Role of Bile Acids in Fatty Liver – Mike Shelton Memorial

Presenter: 

Dr. Rohit Kohli, CHLA

At the end of this presentation, participants should be able to:

• Describe the Role of Bile Acids in the Development of Fatty Liver in Children

• Discuss Novel Therapeutic Targets

   Accreditation Statement:
  This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Arizona College of Medicine - Tucson and Phoenix Children’s Hospital. The University of Arizona College of Medicine - Tucson is accredited by the ACCME to provide continuing medical education for physicians. The University of Arizona College of Medicine - Tucson designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  Disclosure Statement:
  All faculty, CME Planning Committee Members, and the CME Office Reviewers have disclosed that they have no relevant financial relationships with ineligible companies that would constitute a conflict of interest concerning this CME activity.

Presenter: Thomas Inge, MD, PhD, Surgeon in Chief and Chair of Surgery, Lurie Children's Hospital of Chicago Professor of Surgery and Pediatrics Northwestern Feinberg School of Medicine

At the end of this presentation, participants should be able to:

• List the indications for use of metabolic bariatric surgery in pediatric patients
• Discuss benefits, risks, and outcomes of surgery
• Review technical aspects of vertical sleeve gastrectomy

Meet the presenter:

Dr. Thomas (Tom) Inge is a Professor of Surgery and Pediatrics with tenure at the Northwestern Feinberg School of Medicine (November 15, 2021-current). He also holds the Lydia J. Fredrickson Board Designated Professorship in Pediatric Surgery and is the Surgeon-in-Chief and Chairman of the Department of Surgery at the Ann and Robert Lurie Children’s Hospital of Chicago. His clinical practice has focused on advanced minimally invasive surgery and in particular, his clinical and academic interest over the last 20 years has been in the surgical care of adolescents with severe obesity. Dr. Inge has been continuously funded by the United States National Institutes of Health (NIH) since 2005 and has been the principal investigator of the Teen-Longitudinal Assessment of Bariatric Surgery study since 2006. He and his team have produced over 150 peer-reviewed publications and book chapters. He has also provided over 150 invited lectures for national and international professional groups. His leadership experience includes prior roles as Chief of Pediatric Surgery and Associate Surgeon-in-Chief at Children’s Hospital Colorado. Tom has also served as a member of the FDA’s Gastrointestinal and Urological Devices Committee, as a consultant to the NIH and the Agency for Healthcare Research and Quality. He has also served in leadership positions on numerous committees and task forces for surgical and pediatric professional organizations including American Society for Metabolic and Bariatric Surgery, The Obesity Society, the American Academy of Pediatrics, and the American Pediatric Surgical Association.